Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 14-Sep 2016. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 96012501000001117 | Fluticasone 250micrograms/dose / Salmeterol 25micrograms/dose inhaler CFC free (A A H Pharmaceuticals Ltd) 120 dose (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 96012601000001118 | Fluticasone 250micrograms/dose / Salmeterol 25micrograms/dose inhaler CFC free (A A H Pharmaceuticals Ltd) 120 dose | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Fluticasone 250micrograms/dose / Salmeterol 25micrograms/dose inhaler CFC free (A A H Pharmaceuticals Ltd) 120 dose | Is a | Fluticasone 250micrograms/actuation / Salmeterol 25micrograms/actuation inhaler CFC free 120 dose | false | Inferred relationship | Existential restriction modifier | ||
| Fluticasone 250micrograms/dose / Salmeterol 25micrograms/dose inhaler CFC free (A A H Pharmaceuticals Ltd) 120 dose | Has AMP | Fluticasone 250micrograms/dose / Salmeterol 25micrograms/dose inhaler CFC free (A A H Pharmaceuticals Ltd) | false | Inferred relationship | Existential restriction modifier | ||
| Fluticasone 250micrograms/dose / Salmeterol 25micrograms/dose inhaler CFC free (A A H Pharmaceuticals Ltd) 120 dose | Has excipient | Excipient not declared | false | Inferred relationship | Existential restriction modifier | ||
| Fluticasone 250micrograms/dose / Salmeterol 25micrograms/dose inhaler CFC free (A A H Pharmaceuticals Ltd) 120 dose | VMP non-availability indicator | Available | false | Inferred relationship | Existential restriction modifier | ||
| Fluticasone 250micrograms/dose / Salmeterol 25micrograms/dose inhaler CFC free (A A H Pharmaceuticals Ltd) 120 dose | Has specific active ingredient | Salmeterol xinafoate | false | Inferred relationship | Existential restriction modifier | ||
| Fluticasone 250micrograms/dose / Salmeterol 25micrograms/dose inhaler CFC free (A A H Pharmaceuticals Ltd) 120 dose | Has specific active ingredient | Fluticasone propionate | false | Inferred relationship | Existential restriction modifier | ||
| Fluticasone 250micrograms/dose / Salmeterol 25micrograms/dose inhaler CFC free (A A H Pharmaceuticals Ltd) 120 dose | Has dispensed dose form | Pressurised inhalation | false | Inferred relationship | Existential restriction modifier | ||
| Fluticasone 250micrograms/dose / Salmeterol 25micrograms/dose inhaler CFC free (A A H Pharmaceuticals Ltd) 120 dose | Has NHS dm+d (dictionary of medicines and devices) basis of strength substance | Salmeterol | false | Inferred relationship | Existential restriction modifier | ||
| Fluticasone 250micrograms/dose / Salmeterol 25micrograms/dose inhaler CFC free (A A H Pharmaceuticals Ltd) 120 dose | Legal category | Prescription only medicine - legal category (qualifier value) | false | Inferred relationship | Existential restriction modifier | ||
| Fluticasone 250micrograms/dose / Salmeterol 25micrograms/dose inhaler CFC free (A A H Pharmaceuticals Ltd) 120 dose | Discontinued indicator | Never discontinued | false | Inferred relationship | Existential restriction modifier | ||
| Fluticasone 250micrograms/dose / Salmeterol 25micrograms/dose inhaler CFC free (A A H Pharmaceuticals Ltd) 120 dose | Is a | Actual medicinal product pack | false | Inferred relationship | Existential restriction modifier | ||
| Fluticasone 250micrograms/dose / Salmeterol 25micrograms/dose inhaler CFC free (A A H Pharmaceuticals Ltd) 120 dose | VMP prescribing status (attribute) | VMP not recommended to prescribe - patient training required | false | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR